News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>M Stanley Raises CHINA LIFE (02628.HK) TP to HKD38.9; Rating Overweight Reiterated
In view of the strong growth in VNB of CHINA LIFE (02628.HK) in 1Q26, Morgan Stanley revised up its relevant growth assumptions. As a result, the broker slightly lifted its earning...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Raises CHINA LIFE (02628.HK) TP to HKD38.9; Rating Overweight Reiterated
Close
Recommend
9
Positive
24
Negative
9
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

In view of the strong growth in VNB of CHINA LIFE (02628.HK)  -0.080 (-0.267%)    Short selling $529.87M; Ratio 43.005%   in 1Q26, Morgan Stanley revised up its relevant growth assumptions. As a result, the broker slightly lifted its earnings forecasts for 2026-28 by 0.1%/ 0.3%/ 0.4%.

Morgan Stanley hiked its TP for CHINA LIFE by 2.6% from HKD37.9 to HKD38.9 and reiterated its Overweight rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-14 16:25.)

Related News Daiwa: 2026 Mainland Corporate Earnings Recovery May Accelerate but Not Broad-Based

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.